Product Information

BUPROPION HCL SR 150 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.2650 per EA under NDC 00591354376. Its NADAC has been published 657 times since Nov 28, 2013.

BUPROPION HCL SR 150 MG TABLET

bupropion hydrochloride
$0.2650per EA

Strength

150 mg/1

NDC

00591354376

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

BUPROPION HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA079094

On Market Since

6/11/2009

Pharmacological Classes

Aminoketone
Dopamine Uptake Inhibitors
Increased Dopamine Activity
Increased Norepinephrine Activity
Norepinephrine Uptake Inhibitors

Price Statistics

The NADAC for BUPROPION HCL SR 150 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2650 per EA
All-time high$0.7442 (Jul 15, 2015)
All-time low$0.1923 (Jul 17, 2024)
52-week high$0.3009
52-week low$0.2443
Median price$0.3526
Average price$0.3935
Largest weekly change+70.2% (Aug 21, 2024)
Weeks tracked657
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-4.5%

3M

-1.2%

6M

+6.7%

1Y

-11.6%

3Y

-20.9%

5Y

-16.0%

All

-50.6%

Generic Alternatives

The matcher finds 14 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 71% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of BUPROPION HCL SR 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BUPROPION HCL SR 150 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.2650 per EA (NDC 00591354376), effective Jun 24, 2026.

How has the price of BUPROPION HCL SR 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for BUPROPION HCL SR 150 MG TABLET has declined 50.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for BUPROPION HCL SR 150 MG TABLET?

Since Nov 28, 2013, the NADAC for BUPROPION HCL SR 150 MG TABLET has ranged from a low of $0.1923 (Jul 17, 2024) to a high of $0.7442 (Jul 15, 2015), with a median of $0.3526 per EA.

Are there cheaper alternatives to BUPROPION HCL SR 150 MG TABLET?

Yes. 14 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, BUPROPION HCL XL 150 MG TABLET, is $0.0779 per EA — about 71% below BUPROPION HCL SR 150 MG TABLET.

Who manufactures BUPROPION HCL SR 150 MG TABLET?

BUPROPION HCL SR 150 MG TABLET (NDC 00591354376) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.